You are on page 1of 61

The

.--

EPEC-O
TM

Education in Palliative and End-of-life Care - Oncology

Project
The EPEC-O Curriculum is produced by the EPECTM Project with major funding
provided by NCI, with supplemental funding provided by the Lance Armstrong
Foundation.

E
P
E
C

EPEC - Oncology
Education in Palliative and End-of-life Care - Oncology

M 2


. -

. . .

,
, ,




. . .

. . .

5
1.

2.

3.

4.

5.

. . .

, ,

,
, ,

,

Wolf CJ. Ann Intern Med. 2004.

. . .


+-

. . .


, ,
, , , ,
,

Wolf CJ. Ann Intern Med. 2004.




: , ,


,

. . .

3 (7-10)
Morphine

2 (4-6)

Hydromorphone
Methadone

A/Codeine

Levorphanol

A/Hydrocodone

Fentanyl

A/Oxycodone

Oxycodone

ASA

A/Dihydrocodeine

Adjuvants

Acetaminophen

Tramadol

NSAIDs

Adjuvants

1 (1-3)

Adjuvants

WHO Geneva, 1996.

> 4 gr / 24

, > 2 gr / 24

Mitchell JR, Potter WZ. Med Clin North Am. 1975.

- -1

- 1

COX 1

Carson LJ, Willett LR. Drugs,1993.

. . .



COX-2

Peura DA. Cleve Clin J Med, 2002.

1.

2.

: (ANTACIDS)

: Sodium Bicarbonate

: Magnesium hydroxide, calcium


carbonate
:

H2 : Cimetidine, Ranitidine,
Famotidine, Nizatidine and Roxatidine
: Omeprazole,
Lansoprazole Pantoprazole, Rabeprazole
: Pirenzepine, Propantheline

. . .

(9095%)

Collins SL, et al. J Pain Symptom Manage. 1998.

- 2

30

50
100
50, 100

40 100

30/500, 60/1000

- 3

10
30
10

25
25, 50, 75, 100

max

t1/2 -

IV

SC / IM

Cmax

PO / pr

(t1/2)

. . . . . .

Cmax
PO
SC, IM
IV

1
30
15


PO / PR / SC / IM / IV 4

, , ,
,

30
50
10

. . .

8, 12, 24

10 -
, 1

- 25 %

- 50%

- 100%



= 10%
=
+

- 2

/ 6 =

9095%

, ,

,
,

Mercadante S, Arcuri E. J Pain. 2004.

. . .

...




2-3 50%

...

Cmax
T

24

2/1 72


25

mg 60 mg / 24

, ,
, , ,




, ,

1 = 0.1

Morphine, hydromorphone, fentanyl

PO / PR

SC / IV / IM

150

Codeine

50

150

50

15


- 100%
- 75%
50%

\\

\\

\\

100 PO 3
1-3
9001800 / ;
> 3600 /

1025
1-3
100

,



>36
220


(Tolperisone hydrochloride)

a
150 3
100 2
100 1

E
P
E
C

.

( ),
1.
.
2.
.
.

OSTALON

, ,